Journal Edition sofw journal 4-2019


Skin sensitivity, scientifically called Irritable Skin Syndrome (ISS), is one of the main disturbing skin conditions and remains a growing global concern. Symrise R&D has developed specific cosmetic actives to fight the different physiological reactions that lead to skin discomfort related to the ISS. Each benefit is documented by a clinical study.
SymCalmin® (INCI name: Butylene Glycol, Pentylene Glycol, Hydroxyphenyl Propamidobenzoic Acid) effectively reduces skin itchiness and redness. While SymSitive® 1609 (INCI: Pentylene Glycol, 4-t-Butylcyclohexanol) relieves burning & stinging sensations. And to complete these two actions, recently-launched SymReboot™ L19 (INCI: Maltodextrin, Lactobacillus Ferment) restores and strengthens the skin’s barrier integrity to reduce Trans Epidermal Water Loss (TEWL) and visible signs of dryness.
These three complementary cosmetic actives soothe the skin hypersensitivity by restoring the skin homeostasis.

Back to top

We use cookies on our website. Some of them are essential for the operation of the site, while others help us to improve this site and the user experience (tracking cookies). You can decide for yourself whether you want to allow cookies or not. Please note that if you reject them, you may not be able to use all the functionalities of the site.